Treatment options and unmet needs in pediatric patients with R/R CML

2 Views

07/08/23

Erica Brivio, MD, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands, outlines treatment options for pediatric patients with chronic myeloid leukemia (CML) who relapse after first- and second-line treatment, emphasizing the importance of determining whether some pediatric patients can attempt treatment discontinuation with TKIs. This interview took place at the 28th Congress of the European Hematology Association (EHA) 2023 in Frankfurt, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.